Cyclodextrin-Mediated Enhancement of Riboflavin Solubility and Corneal Permeability

Molecular Pharmaceutics - Tập 10 Số 2 - Trang 756-762 - 2013
Peter W. J. Morrison1, Che J. Connon2, Vitaliy V. Khutoryanskiy2
1School of Pharmacy, University of Reading, Whiteknights, P.O. Box 224, Reading RG6 6AD, United Kingdom.
2School of Pharmacy, University of Reading, Whiteknights, P.O. Box 224, Reading, RG6#R#6AD, United Kingdom

Tóm tắt

Từ khóa


Tài liệu tham khảo

Washington N., 2001, Physiological Pharmaceutics: Barriers to Drug Absorption, 2, 249

Wilson C. G., 2001, Drug Delivery and Targeting for Pharmacists and Pharmaceutical Scientists, 329

Chandran S., 2008, AAPS PharmSciTech., 9, 1031, 10.1208/s12249-008-9139-4

Loch C., 2012, Eur. J. Pharm. Sci., 47, 131, 10.1016/j.ejps.2012.05.007

Gautheron P., 1992, J. Appl. Toxicol., 18, 442, 10.1016/0272-0590(92)90142-5

Tuft S. J., 1994, Ophthalmology, 101, 439, 10.1016/S0161-6420(94)31313-3

Wollensak G., 2003, Am. J. Ophthalmol., 135, 620, 10.1016/S0002-9394(02)02220-1

Roskams, J.; Rodgers, L.Lab Ref: A Handbook of Recipes, Reagents and Other Reference Tools for Use at the Bench;CSHL Press:New York, 2002; p18.

Anyakora C., 2008, Afr. J. Pharm. Pharmacol., 2, 029

Hoving E. B., 1995, J. Chromatogr., B, 671, 341, 10.1016/0378-4347(95)00223-6

Osman H., 2006, Malays. J. Anal. Sci., 10, 205

Challa R., 2005, AAPS PharmSciTech., 6, 329, 10.1208/pt060243

Cal K., 2008, Eur. J. Pharm. BioPharm., 68, 467, 10.1016/j.ejpb.2007.08.002

Chatjigakis A. K., 1992, Anal. Chem., 64, 1632, 10.1021/ac00038a022

Terekhova I. V., 2011, J. Inclusion Phenom. Macrocyclic Chem., 69, 167, 10.1007/s10847-010-9827-z

Higuchi T., 1965, Adv. Anal. Chem. Instrum., 4, 117

Liu R., 2011, J. Pharm. Sci., 100, 3186, 10.1002/jps.22540

Fujishama H., 1996, Br. J. Ophthalmol., 80, 29, 10.1136/bjo.80.1.29

Jarho P., 1996, Int. J. Pharm., 137, 209, 10.1016/0378-5173(96)04522-X

Grove C., 2003, J. Cosmet. Sci., 54, 537

Loftssona T., 1999, Adv. Drug Delivery Rev., 36, 59, 10.1016/S0169-409X(98)00055-6

Sultana Y., 2006, Curr. Drug Delivery, 3, 207, 10.2174/156720106776359186

Roy D. K., 2009, Spectrochim. Acta, Part A, 73, 201, 10.1016/j.saa.2009.01.026

Coffman R. E., 1996, J. Pharm. Sci., 85, 951, 10.1021/js960012b

Zhunuspayev D. E., 2010, Langmuir, 26, 7590, 10.1021/la904403k

Jmol: An open-source Java viewer for chemical structures in 3D;http://www.jmol.org/.

Riboflavin.http://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC2%2FN%3DC%5C1%2FN%28c3cc%28c%28cc3%2FN%3DC%2F1C%28%3DO%29N2%29C%29C%29C%5BC%40H%5D%28O%29%5BC%40H%5D%28O%29%5BC%40H%5D%28O%29CO(accessed online: December 24, 2012) .

Resch M. D., 2010, Invest. Ophthalmol. Vis. Sci., 51, 1024, 10.1167/iovs.09-4254

Resch M. D., 2011, J. Ocul. Pharmacol. Ther., 27, 323, 10.1089/jop.2011.0007

Ishino Y., 2004, Invest. Ophthalmol. Vis. Sci., 45, 800, 10.1167/iovs.03-0016

Azuaro-Blanco A., 1999, Br. J. Ophthalmol., 83, 399, 10.1136/bjo.83.4.399

Fullwood N. J., 1994, J. Mol. Biol., 236, 749, 10.1006/jmbi.1994.1187

Yi-fei H., 2009, Chin. Med. J., 122, 212, 10.3760/cma.j.issn.0366-6999.2009.02.019

Zaidi T., 2008, Invest. Ophthalmol. Vis. Sci., 49, 1000, 10.1167/iovs.07-0993

Ohtani Y., 1989, Eur. J. Biochem., 186, 17, 10.1111/j.1432-1033.1989.tb15171.x